Isaacson P, Wright D H, Jones D B
Cancer. 1983 Jan 1;51(1):80-91. doi: 10.1002/1097-0142(19830101)51:1<80::aid-cncr2820510118>3.0.co;2-0.
Since the advent of the newer classifications of non-Hodgkin's lymphoma and the realization that the majority of tumors classified as histiocytic under the Rappaport classification were in fact of lymphocytic origin, there have been remarkably few reports of true histiocytic (monocyte/macrophage) tumors and it has been suggested by some that such tumors should not be considered as a variety of malignant lymphoma. This article describes five patients with malignant lymphoma of neither B- or T-lymphocyte origin in whom the malignant cells could be characterised immunologically, cytochemically, and immunohistochemically as of true histiocytic derivation. The cases showed considerable morphologic diversity but there were shared characteristics at both light microscopic and ultrastructural levels. Positive immunohistochemical staining for alpha 1-antitrypsin was the single most useful criterion in classifying these tumors. Without the use of special techniques there were no clinical or pathologic features that reliably distinguished these cases from non-Hodgkin's lymphomas of lymphocytic derivation. Tumors of histiocytic origin are, therefore, inevitably being included among the non-Hodgkin's lymphomas and are most appropriately classified as such. Identification of histiocytic lymphomas should be encouraged so prognosis and optimum treatment can be established.
自从非霍奇金淋巴瘤的新分类出现,以及人们认识到在拉帕波特分类法下被归类为组织细胞性的大多数肿瘤实际上起源于淋巴细胞以来,关于真正的组织细胞(单核细胞/巨噬细胞)肿瘤的报道非常少,并且一些人认为此类肿瘤不应被视为恶性淋巴瘤的一种。本文描述了五例既非B淋巴细胞也非T淋巴细胞起源的恶性淋巴瘤患者,其恶性细胞在免疫、细胞化学和免疫组织化学方面可被鉴定为真正的组织细胞来源。这些病例显示出相当大的形态学多样性,但在光镜和超微结构水平上有共同特征。α1抗胰蛋白酶的免疫组织化学阳性染色是对这些肿瘤进行分类的最有用的单一标准。如果不使用特殊技术,没有临床或病理特征能够可靠地将这些病例与淋巴细胞起源的非霍奇金淋巴瘤区分开来。因此,组织细胞起源的肿瘤不可避免地被纳入非霍奇金淋巴瘤中,并最恰当地如此分类。应鼓励识别组织细胞淋巴瘤,以便能够确定预后和最佳治疗方案。